(KLIC) Kulicke Soffa Industries - Overview
Stock: Bonding Equipment, Wedge Tools, Aftermarket Services, Consumables
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.10% |
| Yield on Cost 5y | 2.06% |
| Yield CAGR 5y | 8.58% |
| Payout Consistency | 19.8% |
| Payout Ratio | 3.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 64.7% |
| Relative Tail Risk | -7.59% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.24 |
| Alpha | 45.33 |
| Character TTM | |
|---|---|
| Beta | 1.516 |
| Beta Downside | 1.308 |
| Drawdowns 3y | |
|---|---|
| Max DD | 52.47% |
| CAGR/Max DD | 0.22 |
Description: KLIC Kulicke Soffa Industries January 15, 2026
Kulicke & Soffa Industries (KLIC) designs, manufactures and sells semiconductor assembly equipment and consumables across a global footprint that includes China, the United States, Taiwan, Malaysia, Japan, the Philippines, Korea and Hong Kong. Its product portfolio is organized into four segments – Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and After-market Products & Services (APS) – and serves integrated device manufacturers, outsourced assembly & test providers, foundries, and automotive electronics suppliers.
Key operating metrics from FY 2023 show revenue of $1.03 billion, a gross margin of 38 %, and an operating cash-flow conversion of 85 % of earnings, indicating a strong cash-generating business despite the cyclical nature of semiconductor equipment demand.
The segment most exposed to macro-driven growth is Advanced Solutions, which benefits from the accelerating rollout of high-bandwidth 5G smartphones and the expanding power-semiconductor market for electric vehicles – both of which are being bolstered by the U.S. CHIPS and Science Act and comparable incentives in the Asia-Pacific region.
Conversely, the Ball-Bonding segment remains sensitive to fluctuations in Chinese fab capacity utilization, a factor that can compress pricing when regional policy shifts affect export controls on semiconductor tooling.
For a deeper quantitative view, you might explore the companys metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: -64.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 4.00 > 1.0 |
| NWC/Revenue: 104.3% < 20% (prev 120.5%; Δ -16.15% < -1%) |
| CFO/TA 0.08 > 3% & CFO 85.7m > Net Income -64.6m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 4.64 > 1.5 & < 3 |
| Outstanding Shares: last quarter (52.5m) vs 12m ago -3.12% < -2% |
| Gross Margin: 42.10% > 18% (prev 0.39%; Δ 4172 % > 0.5%) |
| Asset Turnover: 58.12% > 50% (prev 56.03%; Δ 2.09% > 0%) |
| Interest Coverage Ratio: -338.9 > 6 (EBITDA TTM -32.9m / Interest Expense TTM 147.0k) |
Altman Z'' 10.00
| A: 0.64 (Total Current Assets 914.2m - Total Current Liabilities 196.9m) / Total Assets 1.11b |
| B: 1.08 (Retained Earnings 1.21b / Total Assets 1.11b) |
| C: -0.04 (EBIT TTM -49.8m / Avg Total Assets 1.18b) |
| D: 6.22 (Book Value of Equity 1.80b / Total Liabilities 289.6m) |
| Altman-Z'' Score: 14.00 = AAA |
Beneish M -3.41
| DSRI: 0.89 (Receivables 215.8m/247.9m, Revenue 687.6m/701.2m) |
| GMI: 0.92 (GM 42.10% / 38.64%) |
| AQI: 0.90 (AQ_t 0.10 / AQ_t-1 0.11) |
| SGI: 0.98 (Revenue 687.6m / 701.2m) |
| TATA: -0.13 (NI -64.6m - CFO 85.7m) / TA 1.11b) |
| Beneish M-Score: -3.41 (Cap -4..+1) = AA |
What is the price of KLIC shares?
Over the past week, the price has changed by +23.70%, over one month by +32.29%, over three months by +85.42% and over the past year by +70.06%.
Is KLIC a buy, sell or hold?
- StrongBuy: 2
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the KLIC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 57.7 | -18.7% |
| Analysts Target Price | 57.7 | -18.7% |
| ValueRay Target Price | 84.8 | 19.5% |
KLIC Fundamental Data Overview February 07, 2026
P/S = 5.3157
P/B = 3.5464
P/EG = 1.31
Revenue TTM = 687.6m USD
EBIT TTM = -49.8m USD
EBITDA TTM = -32.9m USD
Long Term Debt = 38.5m USD (from capitalLeaseObligations, last fiscal year)
Short Term Debt = 5.89m USD (from shortTermDebt, last quarter)
Debt = 68.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -214.1m USD (from netDebt column, last quarter)
Enterprise Value = 3.06b USD (3.48b + Debt 68.1m - CCE 481.1m)
Interest Coverage Ratio = -338.9 (Ebit TTM -49.8m / Interest Expense TTM 147.0k)
EV/FCF = 40.29x (Enterprise Value 3.06b / FCF TTM 76.1m)
FCF Yield = 2.48% (FCF TTM 76.1m / Enterprise Value 3.06b)
FCF Margin = 11.06% (FCF TTM 76.1m / Revenue TTM 687.6m)
Net Margin = -9.40% (Net Income TTM -64.6m / Revenue TTM 687.6m)
Gross Margin = 42.10% ((Revenue TTM 687.6m - Cost of Revenue TTM 398.1m) / Revenue TTM)
Gross Margin QoQ = 49.42% (prev 45.74%)
Tobins Q-Ratio = 2.75 (Enterprise Value 3.06b / Total Assets 1.11b)
Interest Expense / Debt = 0.06% (Interest Expense 40.0k / Debt 68.1m)
Taxrate = 25.48% (5.74m / 22.5m)
NOPAT = -37.1m (EBIT -49.8m * (1 - 25.48%)) [loss with tax shield]
Current Ratio = 4.64 (Total Current Assets 914.2m / Total Current Liabilities 196.9m)
Debt / Equity = 0.08 (Debt 68.1m / totalStockholderEquity, last quarter 825.0m)
Debt / EBITDA = 6.51 (negative EBITDA) (Net Debt -214.1m / EBITDA -32.9m)
Debt / FCF = -2.81 (Net Debt -214.1m / FCF TTM 76.1m)
Total Stockholder Equity = 837.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -5.46% (Net Income -64.6m / Total Assets 1.11b)
RoE = -7.72% (Net Income TTM -64.6m / Total Stockholder Equity 837.1m)
RoCE = -5.69% (EBIT -49.8m / Capital Employed (Equity 837.1m + L.T.Debt 38.5m))
RoIC = -4.41% (negative operating profit) (NOPAT -37.1m / Invested Capital 841.1m)
WACC = 11.28% (E(3.48b)/V(3.54b) * Re(11.50%) + D(68.1m)/V(3.54b) * Rd(0.06%) * (1-Tc(0.25)))
Discount Rate = 11.50% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.03%
[DCF Debug] Terminal Value 57.05% ; FCFF base≈59.8m ; Y1≈39.2m ; Y5≈17.9m
Fair Price DCF = 8.41 (EV 225.8m - Net Debt -214.1m = Equity 439.9m / Shares 52.3m; r=11.28% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -61.48 | EPS CAGR: -32.77% | SUE: 0.23 | # QB: 0
Revenue Correlation: -69.31 | Revenue CAGR: -16.02% | SUE: 3.08 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.35 | Chg30d=+0.012 | Revisions Net=+4 | Analysts=2
EPS current Year (2026-09-30): EPS=1.44 | Chg30d=-0.058 | Revisions Net=+3 | Growth EPS=+585.7% | Growth Revenue=+26.4%
EPS next Year (2027-09-30): EPS=2.39 | Chg30d=+0.263 | Revisions Net=+0 | Growth EPS=+66.0% | Growth Revenue=+14.4%